Experion Expands National Distribution

Experion Holdings Approved for Distribution in the Northwest Territories

VANCOUVER, BC / ACCESSWIRE / March 23, 2020 / Experion Holdings Ltd. (the “Corporation” or “Experion”) (TSXV:EXP)(OTCQB:EXPFF)(FRANKFURT:MB31) is pleased to announce that its wholly-owned subsidiary Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of cannabis, has been accepted by the Northwest Territories as an official supplier of adult-use cannabis products to the territories’ licensed private sector retailers.

The Northwest Territories is the second Canadian territory with which Experion has announced distribution. The Company is actively supplying British Columbia, Alberta, Saskatchewan, Manitoba, and the Yukon and has an LOI signed with Quebec. Registration with other provinces including Ontario and New Brunswick will be announced soon.

Mr. Jarrett Malnarich, Experion’s Chief Executive Officer, commented “We are pleased to announce our new relationship with the Northwest Territories as it supports our major initiative to build out a complete national distribution footprint. We are focused on developing key relationships with each exchange to solidify our brand, Citizen Stash, in Canada’s legal adult-use cannabis marketplace. Brand recognition and consumer acceptance are key drivers in achieving our revenue targets going forward. Additionally, unique partnership opportunities have emerged from companies seeking access to the distribution network that we have established. Leveraging our distribution will be an important contributor in building shareholder value in the near and long term.”

About Experion Holdings Ltd.

Experion Holdings Ltd. is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, BC.

Experion Holdings Ltd. is invested in a portfolio of products to address a wide spectrum of consumer needs’ including Adult-use, Wellness and Therapeutic, and Medical products.

Experion trades on the TSX Venture Exchange as a Tier 1 issuer under the symbol “EXP” on the OTCQB Venture under the symbol “EXPFF” and on the Frankfurt Stock Exchange under the symbol “MB31”

For further information, please visit the Company’s website www.experionwellness.com or contact Investor Relations, Email: IR@experionwellness.com

Disclosure

This press release contains forward-looking information within the meaning of Canadian securities laws. Although the Company believes that such information is reasonable, it can give no assurance that such expectations will prove to be correct.

Forward looking information is typically identified by words such as: believe, expect, anticipate, intend, estimate, forecast, postulate and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company are not guarantees of future results or performance, and that actual results may differ materially from those in forward looking information as a result of various factors, including, but not limited to: the state of the financial markets for the Company’s equity securities; recent market volatility; the Company’s ability to raise the necessary capital or to be fully able to implement its business strategies; the risks identified in the Filing Statement, and other risks and factors that the Company is unaware of at this time. The reader is referred to the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management’s Discussion and Analysis for a more complete discussion of such risk factors and their potential effects, copies of which may be accessed through the Company page on SEDAR at www.sedar.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies ofthe TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Experion Holdings Ltd.

View source version on accesswire.com:
https://www.accesswire.com/581992/Experion-Expands-National-Distribution